TrialFind
Saved trials
Back to results
Active, not recruiting
Phase 3
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
NCT04006210
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Xenoscience
Phoenix, Arizona, United States
+102 additional locations
View on ClinicalTrials.gov
Official details